Pigmentary disorders worldwide survey: Epidemiology, impact on quality of life and stigmatization Feb. 2024
New international consensus: The role of dermocosmetics in the management of cancer-related skin toxicities Jun. 2022
Infographic on epidemiological study assessing social stigmatization in pigmentation disorders Jun. 2022
A Capsule Containing Hydrolyzed Hyaluronic Acid and Panthenol to Target Hyalurosome and Reduce Senescence and Epigenetic Markers in Aged Skin Feb. 2026
Efficacy of a 2-MNG-Containing Serum in the Treatment of Melasma and Post-Inflammatory Hyperpigmentation in a Population from Senegal Feb. 2026
Efficacy and Tolerability of a 2-MNG-Containing Serum in the Treatment of Melasma and Solar Lentigo in a Population from Singapore Feb. 2026
A Capsule Containing Hydrolyzed Hyaluronic Acid and Panthenol to Target Hyalurosome and Reverse the Phenotype of Aged Skin Feb. 2026
Evaluating a novel, invisible sunscreen with MCE filter and 2-MNG active for enhanced protection against HEVL-induced pigmentation Feb. 2026
IMCAS 2024 Pigmentary disorders, prevalence, impact on quality of life, social stigmatization Feb. 2024
IMCAS 2024 Pigmentary disorders, prevalence, impact on quality of life, social stigmatization Feb. 2024
IMCAS 2024 2-Mercaptonicotinoyl glycine: a new molecule that prevents and decreases uv-induced pigmentation. Feb. 2024
Broad spectrum UVA and UVB photoprotection is vital for prevention and protection against actinic keratosis May. 2023
Feb. 2025
